ijms-logo

Journal Browser

Journal Browser

Natural History in Neurogenetic Disorders: Molecular Characterization in the NGS Era

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 20 February 2025 | Viewed by 1113

Special Issue Editor

Special Issue Information

Dear Colleagues,

The breakthrough of next-generation sequencing (NGS) technologies has significantly changed the diagnostic approach to inherited neurological disorders. NGS techniques allow for rapid and inexpensive large-scale genomic analysis, creating unprecedented opportunities to integrate genomic data into the clinical phenotyping and management of subjects with neurogenetics diseases. In particular, a deep-phenotyping approach is essential for correctly interpreting genetic variants and reevaluating patients who lack a conclusive genetic diagnosis. Some examples include mitochondrial diseases, neuromuscular disorders, hereditary spastic paraplegia and hereditary ataxias. Furthermore, next-generation sequencing techniques provide powerful ways of interrogating the epigenome and, in combination with other omics technologies, could contribute to identifying new disease mechanisms.

For this Special Issue entitled “Natural History in Neurogenetic Disorders: Molecular Characterization in the NGS Era”, we are looking for original research articles and state-of-the-art reviews on the molecular characterization of neurogenetic disorders.

Dr. Guido Primiano
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neurological disorders
  • neurogenetic diseases
  • next-generation sequencing
  • mitochondrial diseases
  • hereditary spastic paraplegia
  • hereditary ataxias
  • neuromuscular disorders
  • neurodegenerative diseases

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

15 pages, 1336 KiB  
Review
Deciphering the Complexity of FSHD: A Multimodal Approach as a Model for Rare Disorders
by Domenica Megalizzi, Giulia Trastulli, Luca Colantoni, Emma Proietti Piorgo, Guido Primiano, Cristina Sancricca, Carlo Caltagirone, Raffaella Cascella, Claudia Strafella and Emiliano Giardina
Int. J. Mol. Sci. 2024, 25(20), 10949; https://doi.org/10.3390/ijms252010949 - 11 Oct 2024
Viewed by 728
Abstract
Rare diseases are heterogeneous diseases characterized by various symptoms and signs. Due to the low prevalence of such conditions (less than 1 in 2000 people), medical expertise is limited, knowledge is poor and patients’ care provided by medical centers is inadequate. An accurate [...] Read more.
Rare diseases are heterogeneous diseases characterized by various symptoms and signs. Due to the low prevalence of such conditions (less than 1 in 2000 people), medical expertise is limited, knowledge is poor and patients’ care provided by medical centers is inadequate. An accurate diagnosis is frequently challenging and ongoing research is also insufficient, thus complicating the understanding of the natural progression of the rarest disorders. This review aims at presenting the multimodal approach supported by the integration of multiple analyses and disciplines as a valuable solution to clarify complex genotype–phenotype correlations and promote an in-depth examination of rare disorders. Taking into account the literature from large-scale population studies and ongoing technological advancement, this review described some examples to show how a multi-skilled team can improve the complex diagnosis of rare diseases. In this regard, Facio-Scapulo-Humeral muscular Dystrophy (FSHD) represents a valuable example where a multimodal approach is essential for a more accurate and precise diagnosis, as well as for enhancing the management of patients and their families. Given their heterogeneity and complexity, rare diseases call for a distinctive multidisciplinary approach to enable diagnosis and clinical follow-up. Full article
Show Figures

Figure 1

Back to TopTop